Large-scale research suggests most commonly listed statin side effects are not actually caused by the drugs, potentially easing concerns for millions of patients.
A major analysis led by Oxford researchers has found that statins, widely prescribed cholesterol-lowering medications, do not cause most of the side effects commonly listed in patient information leaflets.
The study, published in The Lancet on February 5, 2026, suggests that only four of 66 reported potential side effects are confirmed to be linked to statin use, and even those occur in a very small proportion of patients.
Statins are among the most frequently prescribed medications globally because they effectively lower LDL cholesterol and reduce the risk of heart attacks and strokes.
Cardiovascular disease remains responsible for roughly 20 million deaths worldwide each year, making cholesterol management a major public health priority.
How the Study Was Conducted
View this post on Instagram
The Oxford research team analyzed data from 23 large randomized clinical trials conducted through international cholesterol-treatment collaborations. These included:
All trials were double-blind, meaning neither participants nor researchers knew who was receiving statins or a placebo during the study. This design reduces bias and provides more reliable evidence about drug effects.
Patients were followed for nearly five years on average, making the findings particularly robust.
Memory Loss, Depression, and Sleep Problems Not Linked
NEW: A major study from @Oxford_NDPH finds statins are not linked to most side effects listed in package leaflets – including memory loss, depression, sleep problems, and sexual dysfunction.
Find out more ⬇️ pic.twitter.com/05zkfPkyrB
— University of Oxford (@UniofOxford) February 6, 2026
One of the most persistent concerns about statins involves cognitive effects such as memory problems or mental health issues. However, the study found no evidence that statins increase risks of:
For example, reported cognitive impairment occurred at about 0.2 percent per year in both statin users and placebo groups — indicating no causal relationship.
Researchers emphasize that while some individuals may experience these symptoms while taking statins, the data do not support the medication as the cause in most cases.
Confirmed Side Effects Are Rare
Among the 66 potential adverse effects examined, only four showed a confirmed association with statin use, and even then the absolute risk increase was small.
One example is mild liver enzyme elevation detected in blood tests, affecting roughly 0.1 percent of patients annually. Importantly, this did not translate into higher rates of serious liver disease such as hepatitis or liver failure.
Earlier research from the same group also suggested that muscle symptoms often attributed to statins are frequently unrelated to the drug. True statin-related muscle problems occurred in roughly 1 percent of patients during the first year, with no excess risk afterward.
Statins can slightly raise blood glucose levels, meaning individuals already at high risk may develop diabetes sooner. However, researchers stress that cardiovascular benefits generally outweigh this risk.
Why These Findings Matter
Concerns about side effects have discouraged some patients from starting or continuing statin therapy, even when they face significant cardiovascular risk.
Dr. Christina Wright, associate professor at Oxford Population Health and lead author of the study, emphasized that statins have saved millions of lives over the past three decades. She noted that fear of side effects has sometimes prevented people at high risk from receiving protective treatment.
Similarly, Professor Bryan Williams of the British Heart Foundation described the results as reassuring, providing strong evidence that statins protect against heart attacks and strokes with minimal confirmed adverse effects.
Call for Updating Patient Information
@c4newsA new study has found that most side effects commonly linked to statins are not caused by the drugs. As many as 8 million people in the UK take statins to reduce their chances of heart attack or stroke. Academics from Oxford University studied data from 123,000 people, over a period of four and a half years, and found no significant risk of a range of side effects, including weight gain, nausea, depression and sleep problems. #UK #Statins #OxfordUniversity #C4News♬ original sound – Channel 4 News
Lead researcher Professor Sir Rory Collins argues that product information leaflets often include possible side effects based on observational or non-randomized studies, which can introduce bias.
The new meta-analysis, based strictly on randomized controlled trials, offers more reliable evidence.
Researchers suggest revising official statin information to reduce unnecessary anxiety among patients and clinicians, helping them make better-informed decisions about treatment.
Bottom Line
Statins remain one of the most effective tools for reducing cardiovascular risk.
The latest large-scale Oxford analysis indicates that most commonly listed side effects are not actually caused by the drugs, and confirmed risks are generally small.
For most patients with elevated cardiovascular risk, the protective benefits clearly outweigh potential harms.
